Hyperinsulinaemia, insulin resistance, microalbuminuria acid and the risk of coronary heart disease

Annals of Medicine

Volumn 28, Issue 5, 1996, Pages 433-438

  Yudkin, John S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Coronary heart disease; Hyperinsulinaemia; Insulin resistance; Microalbuminuria

Indexed keywords

INSULIN;

CORONARY RISK; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MICROALBUMINURIA; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0029820532     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899608999104     Document Type: Short Survey

References (40)

1. Yudkin JS. How can we best prolong life? The benefits of coronary risk factor reduction in non-diabetic and diabetic subjects. BMJ 1993; 306: 1313-8.
2. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
3. Selby JV, Austin MA, Newman B, et al. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 1993; 381: 381-7.
4. Gray RP, Yudkin JS, Patterson DLH. Plasminogen activator inhibitor: a risk factor for myocardial infarction in diabetic subjects. Br Heart J 1993; 69: 228-32.
5. Jarrett RJ. Is insulin atherogenic? Diabetologia 1988; 31: 71-5.
6. Nagi DK, Rendra TJ, Ryle AJ, et al. The relationship of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin dependent) diabetic subjects. Diabetologia 1990; 33: 532-7.
7. Mohamed-Ali V, Gould MM, Gillies S, Goubet S, Yudkin JS, Haines AP. Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects - evidence against a modulating role for insulin. Diabetologia 1995; 38: 1110-6.
8. Yudkin JS, Denver E, Ramaiya K, Mohamed-Ali V, Gould M, Haines A. Elevated concentrations of proinsulin-like molecules are associated with coronary heart disease in non-diabetic subjects. Diabetes 1995; 44 (Suppl. 1): 59A.
9. Dineen S, Gerstein H. Microalbuminuria and mortality in NIDDM: a systematic overview of the literature. Diabetes 1995; 44 (Suppl 1): 124A.
10. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects: Islington Diabetes Survey. Lancet 1988; ii: 530-3.
11. Gould MM, Mohamed-Ali V, Goubet SA, Yudkin JS, Haines AP. Associations of urinary albumin excretion rate with cardiovascular disease in europid non-diabetic subjects. J Diabetes Complications 1994; 8: 180-8.
12. Foyle W-J, Carstensen E, Fernández M, Yudkin JS. A longitudinal study of associations of microalbuminuria with the insulin resistance syndrome and sodium-lithium countertransport in non-diabetic subjects. Arterioscler Thromb Vasc Biol 1995; 15: 1330-7.
13. Yudkin JS, Andrés C, Mohamed-Ali V, Humphries SE, Talmud P. The deletion polymorphism of the angiotensin converting enzyme gene is not associated with microalbuminuria in non-insulin dependent diabetic subjects. Diabetes 1995; 44 (Suppl 1): 36A.
14. Nosadini R, Cipollina MR, Solini A, et al. Close relationships between microalbuminuria and insulin resistance in essential hypertension and non-insulin dependent diabetes mellitus. J Am Soc Nephrol 1992; 3 (Suppl 2): S56-63.
15. Niskanen L, Laakso M. Insulin resistance is related to albuminuria in patients with type II (non-insulin-dependent) diabetes mellitus. Metabolism 1993; 42: 1541-5.
16. Groop L, Ekstrand A, Forsblom C, et al. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 642-7.
17. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti G. Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 1993; 342: 883-7.
18. Pinkney JH, Denver AE, Mohamed-Ali V, Foster C, Yudkin JS. Insulin resistance in non-insulin dependent diabetes mellitus is associated with microalbuminuria independently of ambulatory blood pressure. J Diabetes Complications 1995; 9: 230-3.
19. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. Hyperinsulinemic microalbuminuria for coronary heart disease. Circulation 1995; 91: 831-7.
20. Baron AD, Brechtel G. Insulin differentially regulates systemic and skeletal muscle vascular resistance. Am J Physiol 1993; 265: E61-7.
21. Baron AD. Cardiovascular actions of insulin in humans. Implications for insulin sensitivity and vascular tone. Clin Endocrinol Metab 1986; 7: 961-87.
22. Bergman RN, Yang YJ, Hope ID, Ader M. The role of transcapillary insulin transport in the efficiency of insulin action. Horm Metab Res 1990; 24: 49-56.
23. Castillo C, Bogardus C, Bergman R, Thuillez P, Lillioja S. Interstitial insulin concentrations determine glucose uptake rates but not insulin resistance in lean and obese men. J Clin Invest 1994; 93: 10-6.
24. Lillioja S, Young AA, Culter CL, et al. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 1987; 80: 415-24.
25. Gray RP, Yudkin JS, Patterson DL. Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: A role for plasminogen activator inhibitor? Br Heart J 1993; 70: 530-6.
26. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986; 314: 488-500.
27. Fuster V, Badimon L, Badimon JJ, Chesebro JH. Mechanisms of disease: the pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242-50.
28. Stehouwer CDA, Stroes ESG, Hackeng WHL, Mulder PGH, den Ottolander GJH. Von Willebrand factor and development of diabetic nephropathy in IDDM. Diabetes 1991; 40: 971-6.
29. Stehouwer CDA, Nauta JJP, Zeldenrust GC, Hackeng WHL, Donker AJM, den Ottolander GJH. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340: 319-23.
30. Agewall S, Faberberg B, Attvall S, et al. Microalbumuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men. J Intern Med 1995; 237: 195-203.
31. Gould MM, Mohamed-Ali V, Xaoubet SA, Yudkin JS, Haines AP. Microalbuminuria: associations with height and sex in non-diabetic subjects. BMJ 1993; 306: 240-2.
32. Hales CN, Barker DT. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992; 35: 595-610.
33. Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clark PMS. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993; 36: 62-7.
34. Phillips DIW, Barker DJP, Hales CN, Hirst S, Osmond C. Thinness at birth and insulin resistance in adult life. Diabetologia 1994; 37: 150-4.
35. Desai M, Crowther NJ, Lucas A, Hales CN. Programming of hepatic metabolism by early protein restriction. Diabetologia 1994; 37 (Suppl 1): A272 (Abstr).
36. Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CRW. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 1993; 341: 339-4137.
37. Stanner SA, Andres C, Poteen W, Lantseva OE, Borodina VL, Yudkin JS. Glucose intolerance and dyslipidaemia - related to intrauterine starvation? The Leningrad Siege Study. Diabetologia 1995; 12 (Suppl 2): S18 (Abstr).
38. Yudkin JS, Stanner SA, Andrés C, Lantseva OE, Borodina VL, Poteen W. Is microalbuminuria and hypertension a consequence of intrauterine environment? The Leningrad Siege Study. Diabetologia 1995; 12 (Suppl 2): S21 (Abstr).
39. Roy S, Sala R, Cagliero E, Lorenzi M. Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci USA 1990; 87: 404-8.
40. Yudkin JS. Hypertension and coronary artery disease in non-insulin-dependent diabetes - cause and effect? J Am Soc Nephrol 1992; 3: S126-34.